Ngenla (somatrogon)

pCPA File Number: 21798
Negotiation Status:
Concluded with an LOI
Indication(s):
Growth hormone deficiency
Sponsor/Manufacturer:
Pfizer Canada ULC
CDA-AMC Project Number:
SR0683
pCPA Engagement Letter Issued:
Negotiation Process Concluded: